Heng Liu
Fortuna: 225 M $ al 31/05/2026
Fortuna: 225 M $ al 31/05/2026
Heng Liu is the founder of LongBio Pharma (Suzhou) Co., Ltd., founded in 2020, holding the titles of Chairman & General Manager.
Former jobs include Deputy Director-Pre Clinical Research at Evive Biotechnology (Shanghai Ltd.) from 2010 to 2017.
Education history includes a doctorate from The State University of New York conferred in 2009 and an undergraduate degree from Shenyang Pharmaceutical University conferred in 2004.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
18,3 % | 04/06/2026 | 13.347.056 ( 18,3 % ) | 225 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.